[PAD]
[UNK]
[CLS]
[SEP]
[MASK]
.
0
1
2
3
4
5
6
7
8
9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
a
b
c
d
e
f
g
h
i
j
k
l
m
n
o
p
q
r
s
t
u
v
w
x
y
z
##o
##t
##h
##r
##p
##i
##c
##a
##l
##I
##D
##s
##e
##n
##C
##B
##y
##g
##N
##T
##1
##f
##2
##6
##5
##m
##v
##u
##j
##0
##8
##4
##9
##b
##w
##d
##k
##P
##H
##R
##E
##S
##x
##V
##K
##7
##A
##3
##M
##U
##O
##L
##X
##z
##F
##G
##q
##Y
##Z
##W
##Q
##J
##ti
##en
##on
##er
##in
##es
th
##ed
in
##al
##at
an
##or
##an
##ro
of
##ati
the
##as
##ic
##it
and
##ar
##is
##ent
##el
##re
##om
##ec
##ation
##ing
##os
##ul
to
##ac
##ol
##ith
##ve
##et
with
##us
##tion
##le
##ly
##ur
##id
pro
re
##um
is
##ut
##ot
for
##ated
##ase
##ig
##op
##em
as
##oc
##uc
##il
##ter
##ess
##ri
##od
##ment
gen
that
##rom
st
##tic
con
##un
##if
##ab
##ts
dis
##ell
##th
de
##tin
##ow
##ere
##ib
Th
##anc
ac
##ents
##am
##ion
ex
##og
##di
##enc
be
##ran
by
##ph
ch
##st
##ress
##ate
##ir
##ity
##NA
su
pati
##ff
##ant
##ap
##te
or
##ver
##ag
com
##ical
##vel
cell
##nd
##ine
##ad
patients
##ay
al
res
sy
on
##ain
##pl
##im
wh
##ep
##tive
##yp
rec
##rans
tre
##hy
are
im
The
##press
inc
##ous
##iz
ne
##qu
ass
was
##ia
##ations
eff
##tor
##ast
trans
gene
se
dise
##ud
reg
##ign
##ence
##igh
##ific
##oci
##enti
##atment
##por
##tein
##ancer
en
##se
ad
##ved
car
treatment
disease
##tiv
##ect
sh
##ome
associ
##atin
protein
inh
cl
ha
ind
at
ap
##ting
mut
##ular
##tr
pr
comp
ph
le
we
##ath
##ch
sign
##pro
have
##ndrom
##ys
##yl
##fer
cancer
##ug
pl
##osis
inhib
In
##unc
##ost
syndrom
##ich
associated
sp
##cri
pre
##ary
##vi
##oth
##ers
##ogen
##pression
##oma
were
##port
##est
from
##aus
##orm
##ari
syndrome
##erap
inf
mod
di
##unction
##ong
activ
met
##ure
been
##ally
ev
##ox
regul
cont
inv
cells
has
##ind
##inical
##ative
effec
rel
ag
##plic
##ore
high
show
##olog
##ies
##one
##erm
inhibit
##and
##ese
##ive
anti
##ased
##uman
##ear
##end
which
##ist
inter
##ym
##up
##oun
fac
cardi
caus
incre
DNA
not
human
##ism
##velop
##af
resul
sub
clinical
We
##RNA
##ator
##ide
function
genes
transcri
##all
develop
##ates
##ord
##ose
this
ar
ab
##ption
co
##umab
##arg
expression
##rial
gro
##rol
signific
##ip
us
therap
path
##ating
dif
##ub
##cl
##ized
##ON
##ases
significant
hyp
##ue
##ens
##iti
may
##uced
##val
mi
bet
resp
tum
##ser
##acter
inhibitor
##ype
no
##ium
##able
spec
##ici
ris
##ucle
factor
##eri
gl
##oid
##udy
non
mic
##ole
mutations
##ther
def
sur
##gen
risk
##age
par
study
sug
am
differ
sugg
##ros
sup
##osph
##ance
##esis
incl
##ob
can
##ke
but
##str
pres
##ang
##oph
includ
tumor
red
##ra
chrom
##ound
##ently
##ugh
un
id
##entif
pol
mul
med
trial
##fter
RNA
##urr
##omal
vari
anal
str
##we
##hyl
##ely
disord
##ech
cy
##ven
prom
##inding
##own
transcription
results
##so
identif
##atic
##ene
##iss
##ility
level
##tions
##amm
development
##ial
##ied
also
##eptor
bi
these
neu
##ark
pot
prog
after
suc
##ween
control
between
receptor
impro
##ential
Is
##idence
##emia
dem
role
##udi
##00
##asm
##ted
invol
mon
miR
bl
##atory
pos
dur
##ple
aut
##ons
del
##ute
##ric
##ace
##ond
##ill
therapy
cor
report
studi
increased
II
##ree
ep
nucle
specific
type
cons
##served
man
cardiac
both
ob
##ective
##way
##ition
##br
phosph
##onstr
##ach
group
Al
its
##rug
##ile
##RC
compar
end
targ
##vere
##aracter
##oll
effective
sequ
##itive
##ions
oc
out
activity
##ight
##ysis
##ail
including
demonstr
##ency
appro
rep
found
my
character
br
pathway
multi
li
lin
int
infl
##pt
##mon
sel
##ass
all
dec
##cess
tw
##pos
use
##anism
##omes
##ments
##trac
form
##arc
mutation
such
over
than
##ulation
induced
during
det
##form
##oding
survi
##athy
##amin
##ection
dat
##ron
des
##ual
dep
##vely
##endent
well
genetic
sc
und
tr
##bo
##ocy
enc
ma
other
survival
##usc
levels
most
more
##ION
##CL
effects
##ort
##iqu
studies
##rec
##emic
caused
suggest
neuro
##rim
##ish
medi
Ca
##mun
methyl
significantly
##US
##ological
10
kn
per
##av
##osomal
pred
disorder
##our
##tern
present
data
dom
##bin
new
two
used
there
##ures
##cin
##emb
target
mal
This
micro
comple
##rad
##tid
indic
##erg
##och
proteins
##agn
it
##eu
kin
enh
##ected
##duc
##ogenesis
sm
their
hem
##ood
##ew
##dition
place
related
drug
ele
he
long
common
analysis
##ylation
##RNAs
tiss
##alc
##ild
reduc
##ormal
##per
low
term
##eral
acid
placebo
##ER
import
##roph
##omas
link
##tis
mech
promot
##ible
ser
##out
rem
kinase
21
occ
hear
lead
##der
had
##iv
model
defici
identified
##TP
##act
acc
syn
##ever
##ard
##ry
##osome
##ization
evidence
binding
##air
CON
##roid
##acy
##itin
me
syst
##CLUS
##CLUSION
involved
##etic
signal
CONCLUSION
##til
##ock
outc
##jor
##ann
##omy
fir
##uk
##ants
##thm
These
##plication
aff
##min
mg
hyper
novel
complex
mechanism
##sp
gli
shown
trials
major
em
##rough
severe
compared
bre
foll
up
##omic
##otic
##rel
prim
##GF
##eration
##pha
TR
##adi
##SC
##onal
##uld
##tine
sever
potential
Ch
sec
##asc
dependent
first
##arly
effect
##last
phase
##ne
effic
improve
##he
polym
##onse
##ety
##ane
##eth
Here
##tim
##ody
under
##wth
genome
arr
##oin
##opathy
##pressed
progress
##ung
sit
##ough
through
##umb
##rib
follow
post
##ogn
who
interac
important
##ak
##ily
##sy
immun
cyt
vit
##olec
##opl
diagn
CD
col
reported
induc
##esting
cause
##ren
known
20
process
##ains
response
mark
saf
##ability
using
##ten
##hes
##ins
##ects
heart
do
fam
##rop
##ack
##opt
##RCA
year
##ET
multiple
el
##alu
regulation
loc
##ok
##over
##eat
##ology
activation
##erase
##lyc
regions
dys
brain
##vid
##AC
##ered
##ited
##hythm
##of
##atal
##annel
efficacy
fail
##tig
only
app
##bed
##uct
sequenc
characterized
hist
mel
##inal
carcin
growth
##itis
molec
##asis
##tical
mice
##ution
##entr
##etal
##urrent
inflamm
mit
enz
##erative
intr
##enef
benef
chang
channel
combin
##ogenic
inhibitors
predic
##are
##ational
##veal
acute
calc
fl
##led
prol
breast
##ascular
##otherap
##ov
thy
play
factors
deficiency
12
##ital
exp
treated
##omen
##usion
##ise
conc
larg
sim
##estig
apopt
antib
ul
##ek
##ful
one
95
Our
musc
produc
stress
##vious
system
fre
numb
tim
##orph
##ult
##tide
signaling
##yn
alpha
investig
##ery
org
phen
##andom
##ophag
##ptom
methylation
based
peri
##dro
CONCLUSIONS
##res
different
##minis
An
##ardi
##reg
es
sk
##ues
##ouse
addition
mat
##owever
sym
imp
##view
showed
tissue
melan
##otherapy
##AD
##oblast
mediated
splic
##ax
requ
isch
decre
small
cases
evalu
enhancer
##rin
##CT
frequ
##ce
##tively
##entric
demonstrated
CT
early
finding
ox
month
CI
##verse
previous
elements
av
dose
three
##ural
##though
enzym
number
To
fib
patient
symptom
##AR
##oss
##phal
arrhythm
##tes
##ste
##oz
##sor
##ex
reveal
thyroid
within
replication
main
##ving
##hys
struct
memb
random
##11
prot
invas
partic
reduced
##eutic
##K2
##ulin
##ities
linked
##alm
higher
sens
##SD
##ingle
##vers
several
##ether
##ophagy
women
##zumab
ins
muscle
sil
##eng
class
##cler
outcome
mouse
conf
highly
##ronic
radi
sam
##AT
##anti
review
##ired
differenti
##iquitin
calcium
some
##IP
##vari
##xim
adv
poss
histone
pat
increase
##varian
rate
##set
##ale
##und
death
expressed
recently
##izumab
association
tumors
phenot
13
##erated
##urther
##ypes
functional
normal
##ian
##arm
##aining
where
contrib
primary
due
sarc
rece
rele
chromosome
observed
deg
##ancy
##ification
therapeutic
single
disc
##ellular
neg
00
FA
##tal
##anced
gluc
phosphor
failure
15
preg
##ymph
##ite
chromatin
into
our
##lish
##its
prof
ref
##abol
disorders
autosomal
correl
descri
organ
free
ovarian
##II
##ND
chronic
direc
regulatory
findings
hy
##ern
child
alter
diseases
inhibition
agents
appear
lymph
##ening
prost
##ement
##irc
transl
RA
day
feat
##ross
time
Rec
##ves
As
those
##ectively
tol
##oles
##idase
week
among
##ness
##eter
##app
##tory
##tration
meth
##ochond
ret
congen
##oblastoma
St
ub
##MT
active
chem
suppress
positive
bacter
plasm
BRCA
PL
cere
hom
pop
##omp
cohes
approved
years
AD
##odies
selective
synth
progression
##oplasm
case
rare
scler
##tain
##erc
metabol
splicing
pattern
fr
line
##imer
##aneous
prostate
wor
##AF
could
like
apoptosis
months
##inant
##plet
events
poly
mitochond
anemia
##ither
##ically
implic
##ize
respons
sites
est
##edi
regulated
previously
##AP
adminis
determ
malign
loss
ol
##ull
##ema
inj
perform
Ad
circ
further
##IS
##erate
stem
##tivity
##vention
##enetic
controlled
influ
changes
pregn
MD
UC
cogn
##22
genomic
sequence
safety
congenital
heter
op
phys
##rh
##onic
##imal
assess
block
leading
family
degrad
features
did
test
##gr
##eli
##essive
##ovascular
bec
##M2
##ising
##etes
resist
##ainst
leuk
enzyme
Ph
po
vir
##RO
ext
neur
indep
repair
##erat
##ests
##astic
##rem
##ulated
many
negative
hep
ventric
##CF
##opro
##oxic
against
second
vitamin
##armac
Do
##RP
prote
oral
dele
consid
mig
when
transcriptional
dam
##az
short
##rophy
symptoms
via
##function
top
cellular
age
demonstrate
occurr
CN
glyc
##Es
##ults
conserved
diab
cardiomy
encod
required
particular
Are
down
val
##etine
##ES
##osomes
##mental
cardiovascular
It
##tu
##cle
##mal
indi
initi
##ication
##ocl
compon
carcinoma
antibody
Pro
##trans
##hib
##roke
inher
metast
surg
inflammatory
experi
simil
##bral
large
AL
Fanc
NF
##line
##IM
##normal
##ule
prov
lower
direct
bone
##ias
recent
recessive
strong
polymerase
revealed
##sch
There
##imumab
diagnos
17
HER
cle
##red
##53
prop
##ablish
##rane
##ause
##uble
meas
hypert
sclerosis
However
tri
##east
##tib
##ality
##ans
##ice
##ethyl
without
expos
altern
delay
mechanisms
following
establish
ventricular
horm
pep
rat
##vis
##ores
##echn
improved
overall
##ryth
##GFR
either
##AM
##OR
expl
##ogene
##ophil
nuclear
##tracellular
hemat
##sych
ischemic
method
degradation
PD
ST
##ele
ess
##ie
##fore
##olution
##opy
##ritis
onset
pharmac
drugs
combination
cri
coding
stim
animal
identify
cognitive
provide
BAC
eryth
##hol
##ick
##igenetic
##encing
agent
abnormal
Although
indicate
promoter
individ
ke
viv
##les
##yc
##asing
##ilast
##thritis
support
variants
approach
##spr
qu
##ake
##NT
##ages
RNAs
##verex
diagnosis
invasive
PC
lung
min
mac
rang
techn
##enib
##reat
stroke
##ologic
domain
melanoma
randomized
11
##ould
##oni
inte
##istic
##osp
nonc
benefit
implicated
essential
vivo
Hir
tra
##otide
##H2
##AL
##orrh
##arb
##istent
occur
secre
dysfunction
sequences
prolif
phosphorylation
ubiquitin
##oplasmic
key
18
30
Am
NS
fetal
##ct
##1B
##vir
##OD
##ised
##ocardi
##ences
infection
pathways
serum
polymorph
damage
similar
H3
mamm
yeast
##ined
region
##afenib
various
##tility
Fanconi
Hirsch
SE
mRNA
pain
recurrent
functions
glioblastoma
interaction
possible
individual
MT
cap
##ix
##KG
##MO
##UND
genomes
respectively
suggests
myel
##uscep
local
##sori
phenotype
children
##sprung
Hirschsprung
dos
lo
oste
types
##row
##sequ
cancers
presence
##ilep
##entral
differentiation
advanced
##ROUND
BACKG
##usceptib
BACKGROUND
IL
lim
susceptib
##ram
##inc
##atid
##agen
##hydro
adj
##plications
III
repres
encoding
##DH
##gi
##UL
##onist
##onserved
while
beta
tissues
molecular
avail
alternative
19
##tag
##CN
##NP
##dd
arthritis
autophagy
models
sequencing
injur
16
25
call
##avi
##zhe
##inil
##alian
##eletal
dist
exc
att
spect
##afinil
amin
variant
epigenetic
Alzhe
formation
dominant
mitochondrial
poor
Does
##oclonal
Alzheimer
BR
lys
might
testing
##rup
##AS
any
##ules
concl
beh
abs
domains
double
arrhythmias
Ex
mort
##ephal
##13
developed
blood
groups
##ocytes
concentr
cardiomyopathy
rati
##gue
##omerase
provid
##operative
##ified
##rosis
population
available
PI
ner
overex
vs
##itivity
##CH
##alth
##ife
##rand
incidence
moderate
##ength
##oprotein
noncoding
fati
##IV
they
acet
exhib
causes
progn
silencing
tolerated
critical
susceptibility
14
24
PU
SU
ver
##king
antag
##tinib
##amine
##irm
##aps
onc
head
##oint
enhancers
CTCF
pregnancy
##remilast
exposure
fatigue
central
grad
##ty
##IF
##yg
##uzumab
##de
##xin
proper
distin
developmental
monoclonal
leukemia
BRAF
Ac
Pati
lat
##vant
##ontin
often
##serv
part
##ission
biom
lik
liver
outcomes
improvement
##orrhage
SL
cran
nec
##li
##TS
##old
##ade
##ands
confirm
considered
50
Di
deri
four
##atively
##itor
##itary
##porter
##oxetine
promising
epilep
famil
period
deletion
proliferation
his
##rac
##12
##atric
##lem
suggesting
smok
hormone
Cp
Cl
coll
cross
rates
set
##ines
##opath
##mentation
Thus
##ateg
recom
recogn
subj
vitro
##overy
##ximab
hydro
plasma
surgery
injury
Mo
Mut
More
fat
lip
p53
psori
##ties
prec
##ogenetic
transcribed
pathogenesis
cycle
##traconserved
safe
plays
impair
decreased
diabetes
delayed
mortality
PT
vas
##son
##NF
##SA
angi
general
##ably
##aging
miRNAs
##urrently
neurop
skin
recei
profile
amino
##ner
##PA
##rob
orig
##ept
biomark
Ap
body
sol
##DA
##ge
##15
##Rs
##ately
##opo
strand
##seud
aden
resulting
##bry
##ergic
reduction
inflammation
weeks
virus
independent
behavi
ratio
Patients
Can
MM
Wh
cr
wide
##eg
##xic
##arr
##otoxic
##tinal
##stand
regulator
result
##rolog
##ochem
##ozyg
suppressor
crani
received
05
foc
rap
##cal
##N22
##fi
prob
##tered
being
##pheral
##aper
whether
##eps
adverse
controls
CpG
ec
life
##iven
##yz
##VA
##LD
##omide
##olip
##adder
pren
prev
##oung
##icial
##angi
myocardi
useful
##ique
hemorrhage
contribute
resistance
NE
PTP
SR
great
less
lab
##enia
##osyn
##utaneous
##amic
complet
##ples
##entially
emerg
induction
investigated
cohesin
range
integr
DC
bind
current
lit
pseud
tem
##enz
##elial
toxic
depression
##imin
##ports
adults
modification
humans
tumour
manag
suggested
embry
##heum
peripheral
whereas
refrac
malignant
grade
prenatal
PTPN22
200
EZ
option
##17
##tile
##anib
##atis
##reatment
##vement
adult
ultraconserved
skeletal
administration
inherited
EZH2
Con
T3
bas
lack
young
##eting
##NK
##T1
##RF
anomal
##ory
##orti
##ico
##ust
##ostosis
cycl
##rophic
##itinib
001
because
STAT
likely
refractory
Ar
ATP
##NC
##itation
##ental
##apar
inhibited
bladder
scre
trig
membrane
individuals
FGFR
FDA
length
sch
##A1
##leep
stand
ach
modul
##icient
accum
ulc
describ
Recent
chemotherapy
SERCA
100
##tase
##kt
##ense
##lei
reac
should
##ensive
neurolog
deli
studied
health
affected
does
distinct
management
##ortioxetine
Mill
TB
du
##esp
throm
disrup
action
regulates
##ukary
immune
colitis
triad
Miller
Akt
##IC
##ones
thus
sudd
##spec
old
mammalian
loop
SUMO
verte
sudden
da
##ral
##iting
##noid
##atus
##omet
examin
mutant
evolution
increasing
clinically
about
glob
##achnoid
reduce
interactions
structure
##tained
diagnosed
CP
Gu
Park
lig
rich
roles
sleep
ty
##fac
##LA
##tit
##ists
condi
need
molecule
glucose
described
conditions
OR
Sc
bil
cat
however
iod
mo
intracellular
##ecting
tool
##ances
##amide
exerc
infec
relative
diff
##ension
include
##raph
characteristic
processes
release
peptide
##heumat
22
Ab
Wil
eukary
tub
wid
##eur
##rox
##ets
##phen
##genic
multic
strateg
targets
targeted
combined
evaluated
oxidase
same
##ediatric
Wilson
RES
here
##ially
##ling
##DL
##ream
##ured
##ensity
analyz
biological
lines
detected
score
##inson
determine
performed
##ULTS
behavior
HC
HRC
On
Pol
currently
##rich
##utis
##RB
##ature
##arachnoid
##ulum
total
retic
transporter
##ylase
activated
##rosophil
##raine
targeting
CaM
affect
glioma
understand
intra
flu
##appa
rapid
tyros
RET
gran
gast
home
ir
mar
##ture
##cent
##2A
gener
contr
although
assay
enrich
##atinib
nucleosome
manif
##ocyte
channels
migraine
components
hematopo
MoRF
daily
##heumatoid
RESULTS
reticulum
##rosophila
Drosophila
fem
psych
##ois
##rum
##rine
##cy
##sing
##ually
##eling
isl
##amb
phot
preval
##afil
forms
leads
##SCs
marker
topois
properties
epilepsy
##ozygous
Not
Treatment
copy
dil
ed
germ
men
sl
##ior
##OS
##urk
##therm
##ained
##pressive
seem
##ylated
regulating
subarachnoid
##oidosis
chromosomal
analys
remod
progressive
cerebral
metabolism
derived
Mutations
trigg
standard
achie
cis
kappa
rheumatoid
vers
##pts
##ycl
##PE
##37
aneur
##idate
##ilit
seg
##ERT
followed
production
oxid
appears
PLN
work
particularly
subjects
##aparib
exercise
topoisomerase
aneurys
NSD
SDH
loci
##18
##wing
##ECT
##olar
##ogenous
infarc
arter
receptors
elev
frequently
hepat
polymorphism
schiz
Parkinson
RG
each
les
pers
tel
wild
##tf
##ire
##lu
##enal
##erin
statis
status
alone
incontin
##prot
##ipp
defects
amyl
##ophren
potent
##position
encephal
##till
elect
##112
insulin
patterns
influence
strongly
Moreover
AM
ED
H4
Mow
SA
TNF
espec
pri
very
##10
##ATP
##OX
##onin
atten
##ermal
ability
##erious
sarcoma
bacterium
cohesion
rats
spectrum
##ochemical
prevent
##ophrenia
Mowat
especially
No
Using
cand
nico
##DNA
##PH
##EN
##7112
##erous
##ork
condition
across
##rant
sex
##ude
containing
subun
blind
neuronal
secondary
ALS
myocardial
ulcerative
##utism
RG7112
000
CMT
Im
US
cre
kg
late
##yst
##50
##vous
##zema
##ester
##read
##izes
##ifications
regulate
inhibits
antid
hypoth
species
endoth
underg
mean
site
decrease
samples
translational
responsible
HER2
##ospasm
represent
eczema
describe
neurological
tyrosine
29
OB
Sever
hel
sum
##oing
##hip
##CA
##duced
##KII
##JECT
##omatic
##uster
distal
##tinoin
##irub
suff
prevention
modifications
relations
increases
parti
##ophosph
selen
majority
##SCR
beneficial
additional
alterations
metabolic
responses
heterogene
tested
abnormalities
nervous
antagonist
smoking
schizophrenia
40
Gfi
MET
OATP
coun
pur
##orafenib
##ac1
##rix
generation
cluster
##fers
arm
observ
##ocyt
longer
terminal
deficient
correlated
lymphoma
established
neuropathy
##phenyl
OBJECT
##irubin
60
CR
NAD
Ser
five
pi
rib
##iod
##iological
##aut
##gro
antic
##art
express
##tex
facilit
developing
abund
auto
repeat
neuroprot
promotes
systemic
change
apoptotic
##regulation
impact
evaluate
homolog
Phase
occurred
encodes
##viron
called
##opathic
##osynostosis
STAT3
CaMKII
relationship
Burk
Ctf
Sm
pan
palm
vi
will
##oac
##44
##SK
##eness
##alysis
##olate
##stream
treat
transcript
##genase
difference
unc
##omallei
identification
Alu
##posed
design
genetically
median
predis
promoters
##deria
gliomas
TRIM
frequency
sensitive
days
synthesis
physical
##holderia
overexpression
pseudomallei
thromb
manifest
OBJECTIV
Burkholderia
HSCR
Mul
aim
how
still
wa
##IN
##ef
##20
##ination
##ince
##asia
##icin
##omer
##olic
##usions
##uture
exon
order
treating
subsequ
success
approval
depend
##iving
severity
fibrob
##antile
profil
doses
limited
Clinical
origin
anomalies
analyses
kappaB
versus
GB
MS
few
muc
somatic
##ta
##hood
##ru
##lin
##99
##WS
##eline
##ulations
dehydro
resid
##ferase
modafinil
##ubiquitin
potentially
involvement
specificity
consistent
detection
markers
antibodies
glucos
retro
fract
administered
component
directly
animals
PUVA
confirmed
accumulation
edema
OATP1B
TRIM37
26
23
Drug
LDL
ax
gu
led
pub
trop
##gl
##xy
##VT
##anser
##anafil
##achy
##urtherm
revers
##otor
##epress
##iae
transm
##cha
aber
##iciency
differences
newly
matrix
metastatic
macro
occurs
psoriasis
ATPase
FGFR3
remodeling
aneurysmal
incontinence
amyloid
dehydrogenase
##anserin
##urthermore
En
##aff
##arox
##gether
##by
##R1
##FR
##itu
together
##urn
##ucaparib
##play
transpos
##ators
##ensitivity
better
##avor
indicated
heat
prolong
osteop
vasospasm
CG
Gl
box
bodies
given
mes
mass
pul
##ytic
##P1
##R2
##rotic
##enter
##ulf
##actin
##othy
##abil
##ograph
resear
##ploid
recovery
##astatin
adhes
##tiveness
apremilast
##clinical
defined
unique
nucleotide
##euploid
##omics
##regulated
invasion
Among
absence
craniosynostosis
embryonic
baseline
understanding
contrast
dilated
research
28
CY
Tw
Trans
autism
dox
mening
pig
so
##pus
##nown
##known
##EB
##enesis
##onium
aneuploid
##ision
##ulating
##uria
##utes
##ria
##ifically
complications
##immun
whole
##astuzumab
syndromes
activities
agg
intercal
therapies
unknown
involving
##rectile
relevant
Adminis
UCEs
CNS
encoded
quanti
vertebr
CPVT
female
NADPH
02
FIS
Furthermore
ML
Sub
fe
go
idi
pediatric
tRNA
##ient
##ee
##14
##PC
##OL
##ors
##arn
##olamb
##idne
statin
actin
regard
weight
facial
##formation
TRE
##anezumab
##okine
frequent
structural
radiation
receiving
##apping
##tuximab
cleav
propose
##atidyl
provides
Notch
candidate
heterogeneous
Administration
FISH
##olamban
At
CS
For
GC
tachy
##ration
##cRNAs
##lor
##HOD
##ering
##ared
##ister
##ostic
##dip
##ypical
regen
least
##ostatin
infantile
transcripts
coh
epid
allow
scale
knock
microRNA
marked
##tenance
##ereditary
##ernal
resistant
traum
##arbox
angiogenesis
greater
triadin
prevalence
Several
METHOD
autoimmun
33
Food
HR
Re
Un
cult
erectile
magn
##cardi
##ycin
##ft
##alimumab
##activ
##eta
##etase
depressive
recru
##izing
seen
environ
adap
atrophy
effectiveness
super
manner
myopathy
##monary
neurode
Ca2
##nexin
color
processing
prognosis
Scale
oxidative
After
hand
kidne
nanism
##tle
##lastic
##nt
##vo
##PI
##xi
##3K
though
##ette
##uss
##ify
act
##encephal
carri
##ended
interval
resulted
miRNA
coron
phosphat
phosphate
indicating
complexes
induces
predictor
bacterial
##ompe
synthetase
distrib
##olipin
examined
enriched
encephalopathy
idiopathic
DS
HD
Se
TI
bound
dri
find
fold
mild
sed
side
vac
##ious
##aemia
##asts
##eld
##olimumab
##idine
reports
##opic
##tically
display
##ancies
##enced
##stanti
##iratory
##ectal
relatively
subset
##ipot
novo
endomet
remission
postoperative
maintenance
altered
cerevis
metastasis
history
complete
toxicity
marrow
glucosidase
cleavage
METHODS
autoimmune
coronary
cerevisiae
37
AT
Pompe
Wnt
cop
dual
mT
morph
pe
rs
vascular
##oy
##ll
##not
##CC
##medi
##PR
##GA
inst
##aline
##ored
##ison
##leuk
##ides
##otes
##ople
##terol
contrac
extrac
seiz
carb
prac
##iesis
specifically
##erior
chromatid
##brid
methyltrans
reducing
ChIP
cytos
ischemia
fibrosis
sarcoplasmic
discuss
toler
##olesterol
performance
MDM2
neurons
independ
concentrations
binds
homeost
OBJECTIVE
CYLD
##eeism
TREM2
colorectal
DM
Ind
Nod
NOD
Pre
##ietic
##cence
##au
##aur
##65
##PD
##OT
##ont
them
##rey
##inger
##ursor
##umin
##otrophic
##rium
##ower
##ibrey
diphenyl
contain
substr
chromosomes
##venous
biop
scores
trastuzumab
##avir
##tides
##aken
cytoplasmic
investigate
hepatic
methods
conclude
prognostic
collagen
precursor
healthy
iodonium
EDN
selenium
90
AK
EIF
MAP
Non
density
future
hereditary
light
mental
vortioxetine
##ively
##ward
##dele
##P2
##EC
##isting
##tional
isol
##otre
##ilumab
state
##ibility
##enchy
##aden
##adic
##imav
compound
plant
even
##oxif
##upilumab
##ubicin
hypers
included
All
selection
training
commonly
##resp
estim
particip
##erature
##ethylation
acetyl
familial
recomm
biomarker
focus
widely
analyzed
seems
pulmonary
##imavanserin
DN
Hu
JNK
Met
Pl
PK
Res
ben
basis
et
ey
point
rick
sister
##ield
##me
##esium
##orubicin
##rocy
##idomide
##odafinil
disability
deplet
##phosph
##plant
transport
care
mutated
substanti
##alling
1015
enhanced
reduces
##adian
located
##lycer
##ofol
hybrid
circadian
MDD
clear
stimulation
MTH
recombin
screening
disruption
SUMOylation
global
lesions
successful
adhesion
kidney
##xiety
homeostasis
diphenylene
rickets
depleted
Com
Down
High
Meli
TF
iron
size
##iotic
##ebr
##nin
##yotrophic
##enet
##onucle
infer
##rogen
##arch
##urafenib
##otos
##emurafenib
stage
##thalm
##phthalm
apocy
prefer
infusion
diet
##ipine
ampl
##aminergic
therefore
##ardation
##relin
arrest
maternal
confidence
retardation
hypertrophy
approaches
lysosomal
exhibit
literature
infections
elevated
regeneration
##cardia
MTHFR
Melioidosis
apocynin
27
ER
IB
IV
TAL
adip
ill
mach
nor
qual
renal
##oice
##hrelin
##men
##upl
##A2
##atosis
##itr
##iter
##itable
##use
##ustine
##urc
##uripot
progen
proposed
##otype
##ocal
extracellular
imaging
assemb
pluripot
preven
activating
usually
respiratory
variety
##echol
mono
endogenous
colon
carcinogenesis
mainly
radiotherapy
transloc
populations
heterozygous
occurrence
secreted
polymorphic
concentration
lateral
families
lipid
While
cruc
label
germline
SAH
osteopor
MLP
benign
70
Br
Comp
SS
TSC
equ
fer
ln
sus
##iology
##uff
##FS
##eding
##als
##ash
##osin
repl
replic
##uted
acqu
treatments
##aries
##arily
content
relaps
agonist
subs
artic
pathological
inhibitory
epith
##ptogenetic
importance
remains
##thma
CD5
##ropathy
evaluation
translation
mitochondria
determined
open
migration
stimul
myeloid
oncogene
crosslin
biomarkers
Apremilast
bilirubin
gastro
prior
attenu
##esterone
undergoing
##autophagy
tachycardia
sedation
instability
##oxifen
DNMT
progenitor
crucial
34
AR
CH
Fish
MWS
Sotos
cer
core
dyn
fusion
favor
if
ro
spor
##ced
##16
##mit
##EG
##inity
##ativ
##itance
##osum
##accha
##lex
##lying
##idin
produced
fork
##ops
asthma
##terior
##romyc
contin
deubiquitin
##amoxifen
seq
add
##ectomy
plag
##rosp
medull
improves
overl
presented
##ofl
benefits
viral
value
initial
NS5
##rown
subsequent
meningi
traumatic
##arboxylase
endometri
##leukin
##aurin
##accharomyc
##accharomyces
3D
G6
INT
JA
Mari
One
Pend
TC
arom
bow
dim
dyst
finger
golimumab
ghrelin
now
oper
##oh
##kin
then
##ectin
tofac
##emat
asp
stable
recurr
transgenic
atax
Inter
##cription
highl
interfer
##ount
able
##amma
progesterone
position
##plementation
consti
decarboxylase
##formations
male
microdele
promote
locus
molecules
predicted
##eker
refl
inheritance
ubiquitination
Dieker
hydroxy
##enza
deliver
intravenous
hematopoietic
neuroprotective
aberrant
Two
magnesium
##enchymal
##echolaminergic
G6PD
Pendred
tofacitinib
32
80
ASD
BM
Eff
Gen
HT
Med
Saccharomyces
Wern
coc
cod
net
pair
power
vis
zinc
##co
##laf
##fusion
##27
##600
##Vs
##35
##inted
##esth
anxiety
##oring
##rog
##emory
conver
excess
##astaurin
##tra
compos
signalling
plus
##other
inform
potass
involves
affecting
affinity
failed
predict
##axine
##rinary
Ass
BRCA1
SLN
focal
strategy
nicotine
summ
isolated
Fisher
bowel
##lafaxine
potassium
2D
Ep
Me
Mu
OP
QT
Sp
TAD
ear
fatal
hall
motor
ur
##eti
##19
##ED
##arran
##acill
##odium
##amet
before
cholesterol
##ird
alg
efficient
adalimumab
application
##ongation
interleukin
subt
##ordin
arch
##generation
medic
corpus
##arcot
##ocytic
break
Charcot
situ
##ofac
produce
organism
CTF
Tooth
##ARS
sensitivity
organization
Recently
ubiqu
physiological
assessment
deletions
glycyl
diabetic
propofol
represents
MMP
tools
characteristics
granules
achieved
distribution
osteoporosis
Marie
ataxia
Both
Barr
Cast
Calm
DU
HLA
Rac1
Sy
TP
TO
memory
sep
six
vol
valu
##ho
##psych
##aine
##DM
##N1
##vastatin
##beta
##work
##orn
##itan
##isod
##elin
##eck
##ithm
##uring
##ote
##otrop
##odulin
deaf
##apine
##imod
##udd
##ights
inhibiting
Inc
spinal
infants
intervention
correc
##ergy
element
meg
TRH
avanafil
##ximately
correlation
childhood
malignancies
assessed
initiation
experiments
callosum
##leman
##angiogenic
generally
psychosis
subunit
CMT2
Ctf4
##SK9
cohort
quality
##ativa
network
Muen
##acillus
63
HGF
KCN
L1
RT
bar
cig
calm
harb
mRNAs
rucaparib
seps
sorafenib
tamoxifen
##ae
##ECH
##XY
##inally
inactiv
##orb
##olomide
##urse
##urane
##iditan
retin
generated
##romatosis
conduc
##aban
##phyl
suic
albin
whose
index
##allel
superior
variation
promo
##asmiditan
##illain
episod
nucleus
nucleosomes
##ache
self
##arcin
malformations
elongation
investigation
##ozolomide
randomised
##K20
##ompan
##azop
downstream
ALL
measured
pharmacological
erythroid
capac
conclusion
NEECH
##iminary
TBR1
Guillain
slow
infarction
H4K20
facilitate
Mulibrey
GBM
aneuploidy
dynamic
deubiquitinating
aromatic
Castleman
##psychotic
deafness
Muenke
cigar
sepsis
NEECHAM
48
BC
B1
Dis
GF
GARS
Human
IC
TGF
full
hal
hour
optogenetic
ven
##oag
##aw
##lasts
##100
##most
##vac
##uvant
##orithm
##icro
##osing
##olumab
##olytic
proced
##ume
##ope
stabil
##antar
neon
carry
weak
diverse
antipsychotic
causing
mix
defic
medical
consum
obtained
approximately
decline
predom
indicates
occup
##ivolumab
accompan
##oints
##oplantar
induce
require
contributes
influenza
diagnostic
17p
PCSK9
MTI
recognized
impaired
impairment
problem
DCM
piRNA
palmoplantar
designed
quantit
copper
NOD1
EDNRB
HuR
Results
article
sporadic
medulloblastoma
##oflurane
##intedanib
algorithm
##azopanib
##vacizumab
1B
CB
COL
Ewing
H1
HIV
ME
MIC
SNP
ath
gra
miss
nat
panc
pap
##pal
##aqu
##gia
##PS
##esity
##alin
##icke
##uls
toward
##acute
reverse
##otox
##openia
##terase
stability
conj
##ibr
exons
regim
antigen
##afish
coupl
##uclein
defect
amyotrophic
##rosc
uncle
corresp
complement
improvements
largely
systematic
melanomas
##rinting
avoid
member
phenotypes
##lished
bacteria
PI3K
fatty
little
delirium
##titution
islands
partial
wafers
retrotrans
##aroxetine
##ituitary
##ebrafish
recurrence
Wernicke
Calmette
calmodulin
athl
unclear
correspond
AP
De
HS
HF
Long
OS
Ry
TS
pituitary
serious
##oform
##pite
##point
##CD
##1b
##voflurane
##RS
##eric
thal
##alt
##alpha
##orf
##omb
##osity
##urg
##ophys
##elling
bevacizumab
chaper
##verg
neph
neural
eng
clos
##try
##tric
signs
##ndrome
##estat
##ucleotide
differential
supp
##oblastic
polyn
analog
delet
phospholamban
despite
hemangi
acids
serot
series
cytotoxic
CD99
##overed
enzymes
##ext
structures
discovery
PLB
PLK2
become
valid
measles
myeloma
acetylation
exhibited
antagon
psoriatic
Guerin
eukaryotic
eukaryotes
fluores
##ocytosis
expressing
seizures
##ontaneous
MAPK
##otretinoin
eye
Syndrome
albinism
promoting
capacity
athletes
polyneu
45
67
Aut
CRP
EGFR
MA
SM
ZF
budd
eth
eRNAs
ful
good
hot
ion
vemurafenib
##IR
##TR
##23
##uous
##47
##bi
##itous
##opaus
##emaline
##erebral
##encies
spontaneous
shows
##ording
coordin
course
##struc
duration
cortical
phosphatidyl
ocul
desmin
##iques
##aves
enhanc
terms
synuclein
signals
underlying
prolactin
Analysis
splice
members
correlates
Phosph
techniques
attack
provided
necrosis
recognition
temozolomide
rapidly
##2AK2
mTOR
EIF2AK2
crosslinking
ubiquitous
KCNQ
MIC2
budding
##opausal
35
AC
Bi
ES
FUS
LSD
Man
Micro
PAR
SG
Vortioxetine
back
cal
catal
doc
gr
om
sulf
urinary
##ld
##sm
##1p
##face
##enin
inn
##acement
##urb
##ocutaneous
##ilizumab
convention
##thenia
acting
along
almost
transient
energy
clon
left
activator
showing
##alleng
cyst
demonstrates
intro
selected
allele
microRNAs
upon
marks
appar
product
##cephal
siltuximab
##ATION
pregnant
CNVs
surgical
experimental
emerging
multicenter
behavioral
endothelial
fracture
macroautophagy
Gluc
mesenchymal
doxorubicin
carriers
methyltransferase
independently
hypersensitivity
pluripotent
hours
pancre
polyneuropathy
39
43
Af
ACT
Co
CAD
DI
DO
GA
Hyp
NOT
NXY
Ob
aro
bath
ever
gest
mid
turn
upt
uveal
ves
zebrafish
##eed
##T3
##21
##X4
##ened
##inated
##estis
intrac
##asthenia
##itect
##acet
##olol
##oline
repro
refer
##ocys
##ogl
chain
##ploy
##eptin
modified
diverg
meta
intern
interest
respond
polyp
##illary
obesity
##embrane
males
##alcanezumab
termed
##derly
##oplastic
prediction
##testinal
membran
differentiated
BRCA2
UCRs
CNEs
Therefore
hypertension
PCR
NS3
199
lysine
nerve
catenin
diffic
strategies
artery
statistically
hypothesis
predisposition
vertebrate
superf
assembly
preventing
summar
neonatal
COL1
conventional
Cancer
CRC
Dise
Desp
Has
MV
Most
Over
Pimavanserin
Rel
Sel
TERT
VPA
With
dig
ham
lum
nas
paper
rar
rod
si
typical
##rg
##ramm
##glycer
##HD
##EL
##32
##tif
##entin
##esia
third
##ateral
##atitis
##osa
##ula
##ettes
##uscl
isoform
##ocellular
stor
conn
##iffer
deple
##tinuria
##ranolol
sevoflurane
comput
cardiotoxic
significance
pathogenic
hyperm
##oids
defin
paramet
##obacter
variable
bias
programm
comparison
##ource
presenteeism
reductase
accel
throughout
elderly
proton
lymphoblastic
cereb
homocys
linear
establishment
technique
localized
adjuvant
oncogenic
SLC
##ega
tumours
ligand
diffuse
creatin
profiles
much
published
recruit
thought
phosphatase
Nod1
epithelial
information
DUX4
##orbid
predominant
accompanied
quantitative
natural
fully
uptake
Despite
homocystinuria
31
CA
Cons
Myc
SD
V600
bal
bro
bir
gamma
mil
nivolumab
ophthalm
paroxetine
sw
squ
vag
word
##tam
##put
##IT
##CM
##bur
##alact
off
##icon
##ises
##entan
##ector
##action
##etra
##lybur
##idor
##otrans
##ocarcin
stages
deacet
Three
acts
excl
resection
restric
areas
##poral
event
##endym
interact
pathology
respect
surface
##generative
ependym
consist
multiform
##ochrom
serve
affects
efficac
interacting
carcinomas
enzastaurin
##axis
##versely
classification
##odiesterase
olig
blocks
proteas
consider
technology
headache
setting
modulate
TBI
hematopoiesis
persistent
antidepress
abundant
abundance
fibroblast
##plantation
meningiomas
dimension
constitu
cocaine
architect
separ
gravis
serotonin
Glucose
##oglob
Disease
creatinine
birth
##lyburide
multiforme
AS
Bec
Cell
Fox
Further
Pf
SET
Since
bel
cent
gain
put
since
tend
text
##pose
##ier
##lation
##ea
##BC
##mustine
##ux
##40
##EP
##75
##38
##tious
##enitis
##intestinal
thi
##alog
##orpor
##elet
##urativa
##idrad
read
retinal
##odermal
##tice
diss
exam
chains
challeng
##tez
once
##astat
carmustine
##ched
##ologies
##itide
suppression
stridor
monitor
constit
obj
twice
##CLC
remain
##tilis
CD44
##ultaneous
##oblastomas
##ARD
sample
advant
polyaden
extrem
topical
hypertrophic
##opyr
origins
options
evolutionary
island
##ophosphat
anticoag
homologous
OATP1B1
OATP1B3
CGI
HDAC
##mediate
tolerability
bioprinting
IBD
TALEN
##itrull
replacement
acquired
favorable
17p13
##otoxin
Many
omega
Afric
NOTCH
rarely
storage
depletion
efficacious
##idradenitis
42
He
HIP
IH
Par
RR
Sim
Some
SERT
Tub
best
brown
derm
fil
hipp
##C1
##folate
##24
##58
##VD
##M3
##ales
##ortic
##anz
##itone
##aria
##els
##oman
##omere
toc
iss
isotretinoin
##ococ
##ocam
##abine
degeneration
##ogether
##plasia
##ypic
enab
shock
having
learn
##protein
modulation
agenesis
antiangiogenic
pathophys
tumorig
##raz
##radi
endostatin
characterised
intell
formed
percent
thereby
##tidine
##odyn
inducing
elimin
##ledge
concept
simvastatin
##exin
proto
##versity
differentially
phosphorylated
experience
HERG
attem
absent
necess
solid
duplications
loops
hepatocellular
statistical
antidote
##ography
##ifying
carbox
substantial
##enetetra
machin
##menopausal
gastrointestinal
values
##imodipine
CMT2D
chaperone
deleterious
ACTA1
difficult
dimensional
##tilisin
anticoagul
HIPEC
hippocam
03
36
49
52
5q
CC
Del
ET
Herc
Neu
Of
RIP
Turc
ble
cation
date
kexin
lasmiditan
norm
odd
vul
##oylation
##h1
##pass
##ioc
##sel
##gin
##grin
##6A
##52
##vic
##vatinib
##kerat
##GD
##onad
anterior
##oratory
##antinib
##ustr
##lyl
rearran
##ument
##ocol
##ileng
##odine
##tics
consequ
##unn
##owledge
##apse
seven
enti
prel
##ylind
plants
##aryn
##oxid
agitation
subtilisin
hypophosphat
##valent
special
##icitinib
risks
program
##illin
phosphodiesterase
ocular
myasthenia
intes
mediate
linker
accur
primarily
TRP
##nea
expected
concern
largest
simultaneous
requir
arrhythmogenic
plasmeps
##RPOS
occurring
peptides
explain
H3K
##ephaly
PURPOS
NEB
emerged
Arab
infectious
polymorphisms
observation
residues
transmembrane
prolonged
regarding
recombination
certain
plagioc
dystrophy
##ohist
##esthesia
convertase
##apineuzumab
cigarettes
consumption
SNPs
LSD1
pancreatic
membranes
##glycerol
recruitment
predominantly
putative
Tuberous
##itoneal
Turcot
odds
rearrang
##ilengitide
PURPOSE
plagiocephaly
01
47
Av
Fab
Gro
Hipp
Id
IP
Lind
M3
Oc
PM
ZEB
cutaneous
eti
leth
libr
nam
nintedanib
pen
press
perm
rad
urine
von
##hors
##ii
##ave
##lo
##lic
##lim
##si
##samm
##ev
##no
##ging
##2a
##ded
##RI
##K1
##MA
##enting
##envatinib
##esized
##alastat
annexin
##oric
##anine
offer
##itol
##ret
##ositol
##olizumab
repress
repression
##umor
##aboz
##ella
##tinamide
##ibly
##amous
##amycin
bypass
check
comm
##ectual
haem
princ
Inhib
subc
paralog
variations
##hylogenetic
biochemical
allel
##ronectin
##ocyste
##ished
hearts
##neum
interacts
##okines
predictive
insuff
optim
glycogen
##ospital
NSCLC
##hydrofolate
adjunc
##lier
generalized
increasingly
motility
irradi
sexual
subunits
helic
##group
fibroblasts
aggreg
statins
##encephalitis
people
substrate
translocation
DNMT3
endometriosis
breaks
missense
corresponding
DOPA
MVII
broad
##ocarcinoma
Because
intellectual
##odynamic
##enetetrahydrofolate
##ylindromatosis
Hippel
Lindau
##abozantinib
04
54
53
Based
El
Jan
Lys
NC
Nox
NIP
Prop
Sil
UV
bacillus
din
eight
fix
her
made
morbid
nod
nine
none
pum
ry
tail
terat
util
##iant
##cine
##aver
##ID
##250
##62
##ued
##bulin
##onide
##esper
##itus
##arone
##omat
proven
##utri
##otal
gender
contex
##abalin
exist
##agl
##imus
search
spati
preclinical
infected
functionally
##rolled
suppressed
promise
monotherapy
detect
tract
knowledge
##duction
hearing
account
according
##omyosin
embed
inducible
flav
products
fibr
arrhythmia
reviewed
132
negatively
retrosp
ADP
frag
optic
##elioma
##azol
##AMP
minor
secretion
adjus
attrib
overexpressed
Activ
##servation
##12orf
059
gastric
endothelin
thrombosis
fractures
axonal
tropomyosin
transposase
feas
neurodegenerative
practice
compounds
estimated
Plasm
relapsed
organisms
inactivation
H1N1
avoided
prolactinoma
FoxO
##ococc
learning
machinery
preliminary
ZEB2
radical
##sammoma
pump
##esperidin
embedded
##12orf65
75
AND
Copyr
C12orf65
Fb
HIF
Kline
NA
NET
Oste
PP
Per
Ret
Tr
TN
cost
dupilumab
far
food
gab
mis
muscl
nit
nemaline
nimodipine
pneum
swe
yet
##pected
##aemic
##IG
##sc
##B1
##ygen
##ges
##f1
##fel
##flex
##mol
##42
##bumin
##XR
##zole
##QT
another
##anodine
##ites
##itant
##elium
##reh
##osine
proxim
##umerous
##uction
##mented
stri
##ifl
deep
exer
##ression
##ressive
##ape
##apentin
nebulin
assign
transfer
adoles
clock
plat
plaqu
##urea
highest
noted
##rolizumab
##gene
parallel
amoxic
multiv
biology
authors
intake
perox
##pert
employ
##umbra
flow
Annexin
protective
receive
organic
sclerosing
wors
world
MDS
extent
extensive
downregulated
##holic
spectrom
PTEN
ligase
MoRFs
segmental
##lux
armodafinil
observations
panencephalitis
view
manifestations
##othyron
knockout
environmental
adapt
cytosk
lncRNAs
rou
Associ
earlier
##ofacial
conducted
##phylaxis
suppurativa
nasal
parameters
squamous
ependymomas
architecture
objective
tocilizumab
Herceptin
hypophosphatemic
intestinal
Fabry
penumbra
Copyright
Klinefel
gabapentin
muscles
Klinefelter
69
78
BD
Dat
Genetic
Ig
Na
OI
PR
TH
Uc
bapineuzumab
cff
den
dop
fron
field
mell
pazopanib
ques
right
sodium
utility
wake
##eh
##Cs
##Nase
##met
##w7
##dom
##OA
##inent
##estr
inner
ana
##omitant
##oses
##ulatory
##acestat
propor
prosp
reas
reach
##ements
##ilot
##thy
##thers
##amily
orally
##agacestat
complication
##ada
##plied
area
areflex
images
near
neut
##entia
enter
compreh
##proic
activates
evid
##oxia
contains
##upus
humanized
##ipar
hypothy
##itiz
biologic
cortex
methylenetetrahydrofolate
malaria
kinases
upregulated
severely
introns
muscular
systems
times
Anti
symptomatic
##ozin
155
pregabalin
fram
blocker
ranging
integrin
##agenesis
later
anomaly
reaction
##espread
electro
help
##oacid
guid
TIEG
recommend
recommended
SSPE
interferon
delivery
episodes
GFP
weakness
towards
coupled
engine
document
##cephaly
accelerated
##alactos
proteasome
antidepressant
polyadenylation
tumorigenesis
necessary
5q35
##oxidant
lethal
pressure
princip
alleles
morbidity
ryanodine
##aglifl
amoxicillin
##othyronine
mellitus
areflexia
hypothyroid
##agliflozin
38
57
85
Bl
Cat
Cardi
CVD
Dupilumab
FXR
ID
Jun
NM
PS
PA
Sh
SN
Sur
Sign
Taken
cilengitide
cabozantinib
dere
fall
hidradenitis
junction
kb
lenvatinib
mim
mob
past
source
vector
woman
##to
##tri
##tub
##rb
##ament
##Bs
##vation
inser
##alk
##ana
##rot
##ics
##itamin
##aring
##ulate
##etoacid
##uration
##idem
##idops
##emagacestat
##uch
##ucel
staining
choice
##aged
restor
##eption
##epine
##ypically
recycl
##hyd
incorpor
##porting
aptam
subgroup
functioning
hypoxia
##angl
##raw
medication
prominent
transcriptionally
improving
trend
making
##ERPR
mechan
##akary
immunotherapy
##ETATION
concomitant
oxygen
reveals
discovered
injection
Addition
valve
##ycycl
macroph
disturb
Acute
histidine
lipoprotein
neuropath
When
regulators
##olipid
lacking
screen
SERCA2a
widespread
irr
trigger
sufficient
##iodarone
##oactive
depends
reversible
vertebrates
cultured
vaccine
extract
amplification
fertility
substitution
reflect
pairs
excessive
megakary
half
mixed
occupancy
problems
regimen
vesic
vaginal
words
Pfh1
thiamine
Delta
bleeding
##unnel
Arabidops
checkpoint
##ococcus
cffDNA
##etoacidosis
##ERPRETATION
##ycycline
Arabidopsis
400
By
BNP
CL
Fac
Gli
Hod
HCN
Jar
Jap
Kanz
My
Mac
NPC
OCT
Rd
RCT
SH
Together
bid
cur
cad
citrull
cylindromatosis
dimer
giant
hospital
ib
lupus
mapping
nan
numerous
others
pent
points
tunnel
vary
way
##oic
##iary
##sense
##BS
##yxin
##gkin
##for
##fect
##mark
##urop
##ks
##HL
##Arg
##34
##MG
##zard
##GE
##inus
##iness
##esoid
##rose
##ashes
##itabine
##elvic
##oster
##osumab
##osensitivity
##ulizumab
##ithium
##id2
generate
##ift
##amp
chol
chlor
##verage
alread
alco
tretinoin
imper
regorafenib
hair
apnea
mutants
compr
##ather
Inf
Intr
##crib
##cribed
##ariate
##upt
coop
defective
##ageal
supports
supplementation
##ophageal
##venlafaxine
nuclease
intact
enhance
synostosis
upstream
##relizumab
##ascent
postmenopausal
##aki
cytoplasm
cytokine
eluc
dysp
histones
intrins
flashes
antibiotic
protocol
possess
possibly
estrogen
older
measures
##ethylated
localization
160
deriv
adenocarcinoma
criter
##arrhythm
completely
basal
needed
multicentric
fluid
assays
NSD1
purified
clusters
##iodothyronine
##ground
panel
aimed
##arnesoid
environment
predictors
substrates
TFII
INTERPRETATION
microdeletion
visual
composition
medications
thalidomide
nephrotic
gestational
hypermethylation
deacetylase
belong
constitute
TRPM2
irradiation
NIPT
fixed
spectromet
Catecholaminergic
recycling
Hodgkin
Jarid2
Japan
Kanzaki
##urope
already
51
AN
BOR
Dc
Depress
Em
Ev
E3
Finally
Le
Mac1
Ne
Oral
PN
PO
PFS
ROS
Sj
Sup
SCF
TM
Ul
USA
XL
base
cAMP
fas
fish
fund
galcanezumab
house
lag
lamin
mur
must
ncRNAs
psammoma
pilot
rob
ster
voice
would
yield
##rn
##pri
##irec
##cents
##cRNA
##fly
##ble
##Ps
##HX
##E1
##LS
##inations
threat
inverse
##itch
##isomy
##reated
tooth
##olved
##urs
proof
reupt
##ucinations
##ters
##romycin
conotoxin
##abase
##apl
orth
resolution
##ypt
see
##ectodermal
shared
hazard
atypical
moderat
diversity
metall
##plicated
antit
intermediate
cardiolipin
Weaver
glut
cann
presenting
reper
characterization
characterize
selectively
linking
remained
accept
TRAF
Chl
array
immunop
coli
##estingly
mitral
expans
ultr
matched
decreases
maintain
##clerosis
phenotypic
discontin
150
organophosph
Asf1
malignancy
cognition
proteomic
proteomics
##tuzumab
triiodothyronine
PDE
pharmacologic
##opathies
prevents
##osynth
Arg
reactions
vertebral
triggered
lesion
telomerase
partially
repeats
##affin
intercalators
epidermal
markedly
##oplegia
AKT1
successfully
adipose
sustained
hallucinations
urge
##etitive
TPM3
suicid
carrying
conjug
RyR2
innate
clonidine
intracerebral
V600E
ophthalmoplegia
##iconotide
pathophysiology
helicase
Siltuximab
context
fibrill
##QTL
criteria
BORIS
robust
##HX1B
moderately
41
93
Cd
DPI
Ed
FT
FOX
GSK
LIM
Lsm
Methyl
NR
NOX
RF
Random
SIR
TG
Trial
cess
dab
fever
host
mir
mill
nature
nascent
ow
pack
pelvic
ra
rash
sof
tests
##ooth
##trocy
##hom
##rc
##cosity
##Da
##eated
##CR
##66
##vance
##bil
##ENT
##SO
##xt
##q11
##erb
##org
##isons
##umumab
astrocy
##ocrine
##odops
star
dev
extra
##aptic
##imot
##eping
share
##chlor
signature
##unctin
modifying
activate
##oxy
effectively
aged
antioxidant
##valumab
nonin
paras
##entification
RNAP
delusions
repeated
##recip
neuroectodermal
mediates
presentation
remo
##related
immunohist
129
expand
larger
phenomen
maint
randomly
protection
confusion
advances
possibility
contribu
FAK
phosphoryl
RANK
suppressing
synthetic
fraction
lineages
##gram
metastases
measure
exposed
erythrocy
minimal
secretase
Americ
capable
SLE
periodic
smokers
adenomas
Concl
Confusion
##ometry
catecholaminergic
achieve
Novel
Immun
suffering
piRNAs
anticancer
viability
residue
##ituximab
##ographic
doxycycline
epidural
AKT
##phosphatidyl
##onuclease
infertility
CD55
Interestingly
microdeletions
TADs
CTF4
venous
procedure
deficit
papillary
fluorescent
ZFHX1B
##structive
attacks
apparent
around
summarizes
siRNA
example
namely
retrospective
Rett
plaque
bidirec
##fecta
imperfecta
spectrometry
reuptake
expansion
cessation
soft
1b
55
62
Cycl
DD
Ele
Europe
Gram
Nan
OSA
Pac
Prol
Rucaparib
Sout
Xrn
aug
bp
cDNA
cotrans
er
eQTL
gem
law
na
phylogenetic
rhythm
rather
trim
tele
##otides
##pted
##citabine
##IH
##IL
##going
##uish
##wide
##kes
##72
##Ab
##UC
##X3
##F4
##onical
thalian
##ora
##orin
##rous
##rozole
##omated
##eted
##etus
##used
rein
##igen
##ilin
disting
acup
access
exome
implementation
##quate
carpal
applied
mutagenesis
##chang
##uncture
modif
modest
effector
reli
aging
##ologous
interven
##ymalt
abor
growing
hypom
strength
epit
demonstrating
brux
microcephaly
microtub
enhances
hypervis
glioblastomas
upregulation
##time
##optotic
##lycemic
flan
maturation
CTLA
fibronectin
##116
sensory
correlate
appearance
##MT1
suppresses
homozygous
lineage
circular
##IST
influences
blockers
protease
peptid
explore
pharmacokine
stimulated
identifying
erythromycin
dosing
load
##CNU
excit
Expression
myocardium
integrity
reactive
tubulin
transporters
photosensitivity
attention
nicotinamide
0001
sumoylation
Gfi1b
purpose
manifestation
profiling
transposon
aggressive
discussed
hybridization
illness
JAK2
aspects
hallmark
subtype
##umetinib
antagonists
MAOA
PARP
international
constitutive
Simil
##razine
carboxymalt
Avanafil
Identification
libraries
NAGA
assigned
TIEG1
murine
antitumor
immunoprecip
##odopsin
bidirectional
gemcitabine
acupuncture
bruxism
hyperviscosity
carboxymaltose
46
44
56
61
76
79
92
Ag
Brug
BCNU
CM
Calc
Des
Early
Hist
Mal
MUL
Rad
T4
TA
bis
edi
gel
gut
glyburide
hE
kDa
null
por
piv
p100
testis
##herin
##come
##DU
##nase
##norm
##vuls
##went
##down
##F1
##inositol
therm
##ater
##atran
##orts
##anth
##aster
##ita
##arf
##artic
##istry
##reen
##osus
##acerb
##oled
##olind
##etr
##urally
real
##tinucle
actions
existing
exacerb
##velumab
reser
white
##epith
imatinib
neigh
neoplastic
next
transition
##udilast
regression
adren
associations
apos
##uglycemic
syndromic
dihydro
relax
relie
agangl
subacute
##rolimus
pathogen
paraffin
##keeping
strain
durvalumab
##RC1
compare
repetitive
myogenesis
##uscular
##rect
neuroepith
##embrolizumab
microgl
indication
smooth
##ivarox
primitive
ChR2
underwent
cytokines
##olecular
##oplasia
dysregulation
timing
melanocytosis
ischaemic
decreasing
##CTION
arrhythmic
classical
degree
organs
States
chemical
implications
responsive
circulating
physici
##RODU
glycoprotein
Pro250
hormones
##icking
mammals
epigenetically
Expl
distinc
Acc
neck
probably
##iveness
##roxine
HCC
HCV
generating
prevalent
arteritis
telomere
AML
prevented
hypothesized
##ING
public
Subacute
allows
handling
boundaries
Metnase
preferentially
replicate
continued
overlap
NS5B
INTRODU
powerful
##otropic
barri
dynamics
optogenetics
##roscopic
retrotransposition
enhancement
Phospholamban
sulfate
superficial
isoforms
##ifferenti
consistently
CD44v
normally
entire
requires
plasmepsins
rearrangements
Propranolol
dinucleotide
spatial
Fbw7
adolescents
denosumab
proportion
comprehensive
dereg
vesicles
HCNEs
housekeeping
##priate
threatening
metalloprotein
reperfusion
acceptable
phenomenon
Brugada
editing
pivotal
##olindone
aganglion
##ivaroxaban
Pro250Arg
INTRODUCTION
09
1q
58
59
74
CX
Cro
Col
Cuc
DRB
Def
End
GS
Gal
Hho
IDH
Low
MG
Mon
Mig
Mod
OCA
Psori
Str
Sch
Sry
Syst
aqu
bur
eas
fission
fetus
goss
py
plei
pembrolizumab
rup
rituximab
taken
vel
##oaging
##treated
##hby
##raf
##p1
##c1
##la
##In
##INT
##BP1
##gib
##fication
##uation
##uana
##juana
##01
##80
##ware
##PP
##S1
##VI
##70
##XBP1
##GG
##enes
##enosis
##edipine
##alemic
anc
annot
##asp
##icular
##entre
##omn
##omab
##acin
##oler
reporter
##igatran
asym
##ocortic
stenosis
confer
##ifedipine
exists
##ogram
##stem
##plastic
##ypii
neither
efficiency
transformation
##atinum
clin
atrial
applications
web
##ferases
platinum
spastic
##arial
##erapy
relapse
##velopmental
##itively
specim
gland
cannot
##opharyn
includes
unus
unex
neurom
controlling
##udies
autophag
comparable
living
intensity
decade
##arcoma
##aminidase
desvenlafaxine
trunc
make
##ologically
##eticholic
Chin
Chrom
##hea
underl
postn
cold
##uctural
mature
sensor
##version
classes
radius
glucocortic
organell
appeared
feature
Ashby
Studies
##imeric
circRNAs
blocking
##gramm
proteome
Prog
Proprotein
##ophilia
hematologic
STXBP1
PCa
##virus
##ixaban
epileptic
laboratory
STAT4
modulates
modulating
thrombo
movement
multicentre
photoaging
hepatocytes
undergo
counter
ribosomal
##INE
fewer
troponin
Enh
aneuploidies
knockdown
neurodevelopmental
contraction
clearance
monoamine
Bruc
Compared
##ematosus
##criptional
Genome
CTF18
baricitinib
suicide
Disord
procedures
deficits
hemangioma
##avesical
KCNQ2
MicroRNA
catalytic
cystatin
every
reproduc
responded
COL1A1
cardiotoxicity
##obacterium
considerable
##oglobin
dermatitis
##ginine
##limomab
##ocystein
adjunct
teratogenic
##utrition
multivariate
employed
reason
hypothyroidism
falls
alcohol
intrinsic
TFIIS
Chl1
fibrillation
##homocystein
RANKL
##phosphatidylglycerol
Xrn1
thaliana
epitope
Calcium
DRB1
Migalastat
gossypii
rupture
Ashbya
73
AA
AF
Austr
CK
Coll
D4
Dic
Dys
During
EC
FF
Fib
Five
IR
MI
MNase
NT
NL
Nor
OH
Post
Reg
Rho
Targ
VE
Will
ather
beli
benz
dend
dimin
green
junctin
lithium
maps
pimavanserin
sn
typically
zyxin
##rat
##rical
##rations
##pers
##itions
##lec
##nutrition
##BA
##galactos
##Ns
##mel
##volution
##96A
##HR
##RNP
##EX
##MAR
##Z4
##tifi
##onia
##inary
##estive
##estern
inade
##aling
anast
anaemia
##itentan
##isagen
##entor
##omod
##osal
##ulosis
##acts
##leucel
prophylaxis
##otyp
##igible
##emif
##ocolate
##term
genotype
##unia
dex
Thal
##pher
##iral
##antad
##adel
align
rectifi
##izations
effici
atopic
##ostat
##ogenomics
mode
antisense
causative
arginine
hypn
##ensitive
paralysis
amount
canonical
unrelated
identifies
bio
black
positively
##onsill
manage
compart
endemic
myocytes
intoler
depolar
maxim
disordered
malnutrition
microb
indications
longev
links
sync
means
hyperhomocystein
##spemif
##aking
immunomod
dysh
intron
##areunia
##rinted
maintained
sensitiz
insight
classic
##undred
sarco
005
Study
##erculosis
polyc
glycos
encode
downregulation
valproic
initially
Protein
experienced
hematoma
1858
dosage
excision
exhibits
vasogenic
behaviour
craniofacial
toxicities
neurologic
duplication
examination
biliary
tuberculosis
females
segments
SDHA
AMP
Import
##artoma
Small
thrombocyt
wafer
aberrations
CGRP
United
adaptive
contractile
methyltransferases
DMD
Preclinical
participants
acetylgalactos
recombinant
machine
lncRNA
relapsing
progenitors
TOP2
volume
venlafaxine
oculocutaneous
enhancing
background
graf
hamartoma
programmed
balance
exclus
##tezolizumab
advantage
Africans
Health
Neuro
##keratosis
programs
Growth
IPF
etiology
##sirolimus
adjusted
routine
Data
neuropathic
Factor
RCTs
citrullinated
dyspareunia
lagging
FOXO
dabigatran
##imotuzumab
trimester
##orinostat
distinguish
interventions
immunoprecipitation
Enhancer
FFPE
##lecleucel
##isagenlecleucel
##antadine
rectifier
##onsillectomy
longevity
##spemifene
acetylgalactosaminidase
2a
86
96
98
Bar
C5
C9
CO
Circ
D1
DMT1
FP
Form
GD
Her
Hep
Have
IT
Li
LT
Molecular
Out
Other
Overex
PY
Prad
PAD
PGD
RPE
R47
SP
Sec
SCN
Src
TD
Titin
Vitamin
cord
dry
fed
fast
fung
farnesoid
graph
gonad
harm
hundred
kind
ketoacidosis
last
mari
mAb
phy
pass
p52
rivaroxaban
soci
semagacestat
senes
talk
tetr
uro
water
##ove
##ton
##par
##pidem
##iatric
##lip
##I3K
##BP
##NI3K
##mC
##mission
##vin
##vascular
##uit
##uary
##back
##wise
##drug
##7C
##ORC1
##inion
thym
##atives
##itonin
##isome
##isions
##revir
##omib
##ections
##osarcoma
##active
##idrotic
isoch
##ots
force
##emporal
##terfly
##ritinib
##odal
##romosomes
acne
chat
chimeric
##apoptotic
##ades
ongoing
##eptide
image
neoplasm
##iaz
##astolic
transplantation
##uded
##ignant
close
apixaban
leg
##prol
##ichromosomes
space
infant
died
diphosphatidylglycerol
diastolic
##oxide
relation
arise
coil
##arge
##ubility
surve
ameli
supple
butterfly
until
multinucle
##issencephal
biogenesis
biosynth
demand
posterior
##ondro
consisting
endo
endonuclease
##ightly
former
encour
neurob
##cination
termination
##acycl
hyperbil
upper
CD4
CDP
2016
##ropo
location
##okalemic
imprinted
protects
sensing
relevance
002
FANC
lymphocytes
Asia
plasmic
homology
blockade
##elihood
extend
cardiomyocytes
##ethylase
erythematosus
erythropo
minichromosomes
macular
##sequestr
limit
##133
overexpress
Diab
PTSD
PTX3
rapamycin
eculizumab
integral
temporal
cycling
intraoperative
enrichment
infarct
prions
Ser96A
ribose
uncom
##omeric
Transcription
CSF
338
cultures
driven
displayed
mTORC1
rs75
##mediately
independence
Indeed
Previous
acetylch
focused
PKA
substantially
attenuated
forks
address
plague
TOP
Incre
corrected
harboring
retinoic
H4K20me
MELD
HFNC
phosphatidylinositol
KCNQ3
ACPA
reference
divergent
polyposis
COL1A2
luminal
Consistent
restricted
NOTCH1
absenteeism
anticoagulant
hippocampus
commerc
Inhibition
insufficiency
MVIIC
##onidegib
feasible
TNNI3K
sweep
proximal
platelet
CopyrightIn
BDV
documented
##tries
cadherin
derivative
##organ
phosphorylates
Conclusions
flanking
neuroepithelioma
Exploding
barrier
Hho1p
unusual
D4Z4
VEGF
Willi
belie
##ratentor
anastrozole
dyshidrotic
polycomb
R47H
marijuana
amelior
##issencephaly
encouraging
hyperbilirubin
##sequestrin
Ser96Ala
CopyrightInformation
##ratentorial
06
66
65
89
ABC
Bcl
Brown
Conserved
Dl
EL
Gly
If
IGF
JT
MRP
Modafinil
Pr
SF
SW
Sarc
Top
Type
TCA
Tofac
UG
Vari
XR
average
bot
cuc
casc
cedi
categ
casp
don
dic
dich
fit
gram
hold
hesperidin
hapl
join
lost
lissencephaly
mapp
molindone
nifedipine
pand
pestis
ter
uc
xen
ziconotide
##oad
##ovi
##tage
##tochemical
##hn
##her
##pr
##pati
##cious
##a2
##amental
##sessive
##eff
##ebi
##gar
##gun
##mt
##mic
##menti
##utive
##den
##dle
##HO
##Rp
##EM
##Ss
##30
##M1
##tiple
##enol
##enamide
##onyl
##onomic
##ertain
inversely
##alia
##orylation
##asone
##icle
##icacy
##isation
##enty
##oming
##ecutive
##osc
##ulates
##ulocutaneous
##acl
##acent
##actic
proved
repressive
##umm
##otemporal
step
const
conservation
Th17
##ameth
beam
##ranib
##phrine
##fficking
##antly
alk
whom
record
immediately
transform
##ighting
shift
leak
##yld
Inv
Intra
spread
diarr
##oxavir
##ounts
hypokalemic
amantadine
##obiotic
##angitis
##raxin
unf
unres
automated
nucleases
conscious
phospholipid
ocrelizumab
appropriate
repolar
decision
##posing
detecting
datas
mediating
##ternal
microphthalm
hemoglobin
##ditional
heav
serine
##umber
vital
##ofib
meli
calcitonin
producing
numbers
##regn
materi
##axel
arrhythmogenesis
##sorption
sarcolipin
releasing
reflux
directed
congenita
Stroke
worse
##AF2
pooled
extended
damaged
##functional
clearly
##ORD
supported
trafficking
excitation
poorer
poorly
absol
Expert
latter
##like
histor
##lemtuzumab
Moebi
solubility
##ochemistry
##ozygosity
##aperitoneal
ulcers
describes
ligands
bilateral
iodine
motif
Abl
analyze
triggers
oxidation
elevation
electroph
electrical
ribosome
Ctf18
palmit
manifested
Multiple
subsequently
##glob
transmit
recruited
ATF4
seizure
Index
TAL1
norepine
##urcumin
lipids
suspected
replicating
attenuates
operative
highlight
highlights
##rogate
composed
subtypes
voltage
##orna
CBT
##ulsive
coordinates
introduced
superfamily
Overall
computational
Mycobacterium
milest
CGIs
issue
enables
percentage
accuracy
Oculocutaneous
Janus
node
##omato
attributed
cytoskeletal
dopamine
prospective
recommendations
SNORD
Additionally
dimerization
ibudilast
cooper
possesses
Depression
XLH
fundamental
##ursive
million
maintaining
erythrocytes
CTLA4
adrenergic
relaxation
distinctive
Chinese
postnatal
organelles
Brucella
Australia
efficiently
TOP2B
ITIH
Overexpression
PADI
biosynthesis
hyperbilirubinemia
JTV
Tofacitinib
cediranib
pandemic
Moebius
08
72
77
99
AB
AU
Aft
BCL
Borna
Cy
EGF
ESC
FS
Fas
Function
GR
GW
Gast
Gene
Given
GDM
Hox
IM
K20
LI
MY
Marf
OF
Pan
PSA
Pazopanib
Sk
SMO
TIM
Use
VA
Yers
aw
avi
avelumab
atezolizumab
band
ci
ca
dL
dental
falc
fash
kary
lay
mosa
noc
nimotuzumab
ori
pf
penet
p38
rice
take
tomato
vess
##pox
##points
##cr
##side
##Cap
##fl
##fib
##25
##2S1
##54
##57
##man
##utical
##932
##draw
##HC
##HE
##L1
##inia
##estic
##esides
##esophageal
##ats
anap
##asive
##elson
##revers
##omol
##ulator
##activity
withdraw
##urora
repressed
##umis
isomer
##utely
##igor
##opod
##odeg
##romised
constr
conformation
##owing
##amil
##ograf
##ranial
suitable
##tegr
compl
##ousands
##tored
transf
transferase
compulsive
##chron
Ins
##ichia
prem
preterm
modes
ages
##andem
antimal
fact
archa
abdom
uses
noise
speck
##uclear
nonsy
amiodarone
supratentorial
preser
presents
prescribed
##angli
strains
bioin
succin
deline
delta
##aceutical
obstructive
obsessive
##ailed
sci
scaff
trisomy
neurot
##rimary
##rade
terminus
promoted
##anned
follicular
##heast
polymer
CD133
2013
2012
2015
2014
locally
##ACT
predicting
calculated
125
produces
##rint
frequencies
oxide
##soral
structurally
##K27
radio
contribution
##plete
determin
assessing
Pharmac
##oprot
Program
propranolol
explored
##ophilins
hematological
PDP
##viral
capture
##agenic
##ASP
providing
likelihood
impairs
soluble
##array
##olipoprotein
completed
integrins
temsirolimus
younger
1000
reactiv
globular
22q11
Abelson
Onc
irrevers
Notably
##enalidomide
SAINT
##105
countries
##growth
transcriptome
pigmentation
goiter
Notch1
culture
superoxide
Severe
vaccination
morphology
extracts
practical
EIF2S1
estimate
Combin
TFRs
dietary
IBS
stimulates
JAK
ASDs
Efficacy
Epigenetic
correction
networks
Disrup
retrotranspos
closely
validated
Autophagy
calsequestrin
Hyper
reprogramm
divergence
rodents
SETMAR
monitoring
advantages
extremely
issues
anticoagulants
concerning
subcutaneous
optimal
##628
##scill
worldwide
front
engineered
Signific
aptamer
irritable
Gliadel
OCT3
RdRp
varying
Evidence
suicidal
MethylCap
SIRT1
##CR4
European
microtubule
peptidyl
Histone
Rad9
neighb
Crohn
Cucumis
annotations
##omnia
specimens
thromboemb
inadequate
syncope
immunomodulatory
thrombocytopenia
exclusively
Prader
phytochemical
senescence
neuroblast
cucumber
caspase
joining
xenograf
##amethasone
diarrhea
microphthalmia
heavy
melioidosis
norepinephrine
PADI4
K201
Marfan
Yersinia
avium
fashion
##932628
anaplastic
scaffold
07
5h
500
71
AAD
Cas
Cri
Could
Currently
Center
E2
Esch
ESCs
FGF
FCM
Ge
GL
GTP
Glyburide
LY
LQ
MK
MFS
OM
PH
Pot
Prel
Pick
Red
Ras
SK
Saf
Syn
Single
Six
SCD
Sclerosis
T2
alemtuzumab
bul
cry
dram
ect
hr
hs
hind
hER
iP
joint
log
lact
mood
mmol
oil
pal
pic
pyl
p50
rh
rule
tisagenlecleucel
tandem
vorinostat
warran
yes
##treatment
##turn
##ror
##ril
##pation
##iximab
##na
##ylyl
##5A
##modal
##vasive
##benz
##k2
##H5
##xate
##AIP
##36
##enuous
##eratin
##erichia
##ini
thousands
##eded
ineff
antiv
##orh
##orter
##orge
##round
offers
##asian
##iction
##icated
##itud
##itting
##isk
##elf
##retion
##ingful
##olysis
##olpidem
##ota
##otomy
##ocur
##ilaz
##esseng
stop
strom
confers
disch
depressed
Thr
##ame
exchang
##ogren
##oglyc
##stood
albumin
nearly
assum
ens
enlimomab
##ectable
shorter
clar
apo
leaf
##ylate
Intern
##crimin
diving
divalent
interp
abol
hypo
##rosome
supporting
canagliflozin
##angu
RNAi
strati
bile
potenti
mononucle
cortic
epigen
comparing
comparisons
ends
endocrine
multimodal
infliximab
formula
sca
encoun
mostly
neurotrans
##rimocl
methylated
knife
microbi
##erging
##alcit
lowered
emph
##head
##timately
understood
posttrans
cytogenetic
colonic
mitogen
mitophagy
intraperitoneal
##ovir
thyrot
thyroxine
##fulness
productivity
matter
smallpox
##entricular
##ART
##steine
invasiveness
insights
##armaceutical
glucur
alteration
methotre
chemotherap
suppressive
Adalimumab
opinion
indirect
similarly
NF2
hypertensive
exploding
##hold
traits
similarity
adjacent
attach
ratios
necrosome
Mutation
##robacter
solanezumab
emergence
DCI
2006
Cont
sleepiness
##factor
tuberous
HCl
HCM
Polyc
triggering
segreg
SDHAF2
##ipping
TNFAIP
blinded
meaningful
CREB
neuroprotection
guide
##avorable
pigment
pigmenti
cohorts
Review
vacu
##notobiotic
ChIPnorm
tolerance
DMARD
hybrids
inferior
preventive
Compar
epithelium
ARG
continuous
meningioma
Median
paired
Assess
OPAL
harbor
episodic
coupling
##roscopy
TSH
SMN
innov
GAA
referred
switch
##oglobulin
IHC
attempts
specialized
perme
repressor
Nox5
UVB
utilized
flavination
FoxOs
HIF1
Osteogenesis
peroxis
question
##iparum
mobile
##hydr
macrophages
elucid
antibiotics
##arrhythmic
Sjogren
glutam
discontinuation
organophosphate
package
astrocyt
##chloride
contributing
software
eQTLs
##ifferentiated
metalloproteinases
CXCR4
neuromuscular
underlie
reproductive
dexamethasone
hypnotic
intolerance
hyperhomocysteinemia
PYY
##lipid
##prolactin
##ondroplasia
rs75932628
acetylcholine
TOP2A
UGT1
##globin
SNORD116
BCL11
falciparum
abdominal
##soralen
irreversible
neuroblastoma
5hmC
Escherichia
Preliminary
Safety
dramatic
hERG
##turnal
antiviral
##essenger
##rimoclomol
methotrexate
TNFAIP3
2A
2q
5p
81
88
83
97
Aurora
Bre
Bay
Bax
BBS
Dec
Fe
From
Foll
Goma
Glyc
Galcanezumab
GIST
HG
Hesperidin
Its
K27
Loss
MP
MO
OL
Ovarian
PAS
Pediatric
PWS
Pregn
RB
Rese
Risk
SC
SB
Surg
Such
TK
Tel
Testing
TUC
Vemurafenib
Western
aer
aid
aortic
bor
dog
hard
ip
kern
keratin
lt
las
lom
lif
live
lob
messenger
ospemifene
oscill
pa
rif
rab
rational
sib
sph
sports
satis
tonsillectomy
venti
veh
##rig
##pan
##iologic
##lated
##less
##lorph
##Bi
##gf
##fu
##fen
##67
##morph
##vice
##uits
##born
##wi
##PL
##PAP
##x1
##3A
##Ms
##F72
##enn
##ention
##onym
##ert
##int
##inavir
##atac
##atell
##oradi
##oronal
##roc
##icoronal
##is1
##isition
##elines
##retin
##rept
##omm
##ecestat
##acol
##olin
##levi
##uric
proprotein
revolution
##otypes
##otgun
##ucasian
##ritic
stret
##abis
discrimin
##thelial
Thy
exact
##ogaster
##teen
##ineural
allevi
neoplasia
transduction
##ighted
cartil
shap
shotgun
associates
inhal
lev
##athec
Initi
sparing
modality
metal
contro
ago
antiarrhythmic
interc
intergenic
face
subclinical
abort
abrog
above
##ubecestat
##ensively
rise
define
surrogate
##genesis
inclusion
##strual
strenuous
cytored
##acea
##illance
obser
comparative
endpoints
output
myc
myocyte
intensive
selumetinib
mutational
deterior
##aminase
destr
makes
mediator
Caucasian
newborn
microarray
indicator
##anning
##omycin
CDK
colocal
##ropin
brainstem
intragenic
intrathec
playing
concurrent
melanogaster
spliced
evaluating
##stead
silenced
radioactive
normalization
007
##III
weekly
polyubiquitin
circRNA
circulation
##ISPR
UCR
physiology
##rhodopsin
leukaemia
poison
neuron
initiated
ALDH
##ORT
##ORF72
abnormality
quies
macitentan
traditional
##H2A
##orrhag
secretory
ubiquitinated
myelofib
limb
limiting
250
Acid
periods
collected
adenylyl
embryo
2009
Conversely
cyclic
modulator
needs
granule
##thermic
aneurysm
##luores
candid
create
suffered
CRISPR
##iodine
facilitates
viable
OBJECTIVES
##omeres
mucosal
LDLR
##glut
reversed
Enz
regarded
DSB
DSBs
contractility
themsel
biopsy
##me3
ERK
adipocytes
pluripotency
equi
ferric
acquisition
stimulate
DNMT1
interference
constipation
BMS
Effects
Medic
Meis1
##allelic
BCG
GFI
regimens
closure
677C
introduc
apparently
Obeticholic
middle
turnover
rodent
connective
separate
##eleton
##tezomib
HDAC6
dermat
filament
elimination
##keratotic
consequences
insufficient
MVIIA
##odynamics
##azolam
Activating
##gestion
adaptation
Association
Associated
questions
wakefulness
anaesthesia
Cardiac
insertion
megakaryocytic
Delta27
Emerging
Mac1p
TMZ
TRAF1
own
American
cotranscriptional
teleost
deregulated
sensorineural
glucocorticoid
Collectively
atheros
microbial
1858T
AMPK
C9ORF72
FPGA
Outcome
Second
tetracycl
urothelial
surveillance
formerly
overexpressing
believed
PrEP
Sarcolipin
cascade
dichlorph
fitness
repolarization
milestones
Aft1
FSHD
MYC
mosaic
transfection
antimalarial
speckles
succinate
radioiodine
retrotransposons
reprogramming
Cas9
George
pyloric
International
scaven
Polycomb
UGT1A1
BCL11B
Gomafu
Research
lomustine
rabb
vehicle
##atacept
abortus
myelofibrosis
themselves
dichlorphenamide
68
64
6q
84
91
Aven
BL
Bacillus
Besides
Cyld
DH
Det
DUS
ECM
Fl
Fif
Grade
Hi
Hom
HT1
IF
INP
ICH
Ki
Kv
Kore
Lu
LO
Lasmiditan
Lenn
MF
Mer
Mit
MIM
MSCs
Np
None
Nintedanib
Pb
PRC
Primary
Rac
Sl
Sol
Set
Scrib
TL
TAM
Und
Ver
VHL
WE
XP
bu
boy
cut
cys
cros
cef
dr
der
ded
dest
ether
erad
euglycemic
fo
gir
gnotobiotic
ju
just
la
let
mt
night
pet
pod
pancy
ray
rend
round
sap
spl
sick
te
tric
tau
taking
ve
waves
##tt
##topenia
##pred
##ients
##ces
##cutaneous
##cape
##ler
##lational
##Is
##sti
##equ
##ying
##ger
##gow
##2B
##29
##ject
##90
##bal
##dinal
##V6
##AE
##39
##MS
##OC
##G2
##G5
##tial
##ona
##erating
##inacea
##albumin
anch
anesth
##ask
##asion
##asatinib
##asgow
##itour
##rees
##omotor
##ecovi
##ings
##osts
##idone
##idaz
prolyl
isopro
##utable
##opa
##emann
##ilateral
##terenol
genitour
states
construc
convuls
##abin
deb
devi
##ibanserin
export
examine
exogenous
##ogonad
##phan
##phet
chocolate
##aprevir
##verted
commun
complicated
resc
##plate
recess
imple
implantation
They
##quently
efflux
enable
cardinal
computed
phases
##ches
plac
plastic
Indi
span
sperm
premen
##othelioma
##portun
evolved
##oxorubicin
agon
antiep
antiapoptotic
##ympan
causal
notably
genesis
arising
ablation
absorption
abatacept
##ubation
hypogonad
##thern
deform
untreated
mulibrey
##weight
prompted
positions
coronal
nuclei
manip
##bright
endocytosis
multidrug
multifunctional
intense
decades
forming
##forms
##formin
desire
trace
encomp
neurofib
##rimat
methylator
peritoneal
##avour
##ework
hex
##ildren
reductions
##rophil
serous
service
remark
remov
##TPA
hyperkeratotic
complexity
emo
primrose
Children
importantly
CD40
2017
2010
elic
dysmorph
apply
intram
predicts
simple
##ynaptic
investigational
##reshold
smaller
CTR2
enzymatic
silico
classified
##ATA
deaths
133
released
lymphoid
synthase
working
implicating
injections
Adv
circum
pregnancies
UCSs
genomics
opportun
leukocyte
hepatitis
ventricle
##oprote
proteases
ageing
cardiomyocyte
Prote
hormonal
critically
trait
H3K27
excretion
PI3
##oproteins
fourth
Class
subjective
hydroly
PTC
##geal
NEMO
integration
integrated
MoRFpred
psychiatric
analysed
persist
Gfi1
observational
Smad
predisposing
dependence
originally
kappaB2
axis
guan
osteopenia
Glasgow
soil
##PCs
allowing
trauma
phosphatases
boundary
DMRs
Nod2
##ontrolled
hypersensitive
participate
etc
eyes
##lycerides
illustr
replisome
CD56
gastroesophageal
overlapping
TCS
dystroph
hydroxybenz
delivered
Medical
code
##co1
Spec
TPM2
##DMARD
megacol
cigarette
mixture
complementary
systematically
siRNAs
##329
computation
definitive
SDs
restriction
challenge
TALENs
hippocampal
vulv
vulgar
simultaneously
##load
Inhibitor
aggregation
heritable
attributable
feasibility
Plasmodium
pneumonic
striking
exerts
worsening
cytoskeleton
##thyretin
evidenced
framework
principle
Survi
junctional
mimetic
subgroups
mechanical
macrophage
disturbances
Macro
cholangitis
Japanese
fasting
lamina
PDE5
Edn
GSK3
NOX5
Randomized
noninvasive
parasite
removal
immunohistochemical
expanded
naive
modifier
reliable
hypomethylation
pharmacokinetics
exacerbations
dihydroxy
microglia
aganglionic
##ograms
CKD
NLM
##otyping
Baricitinib
social
neoplasms
multinucleated
erythropoiesis
commercial
##patient
recorded
unfavorable
consciousness
datasets
historical
transmitted
Gastaut
withdrawal
##igorous
##oprotective
AADC
picture
ineffective
discharge
abolished
corticoster
encountered
##onymous
##atellite
ALDHbright
candidates
Enzastaurin
Avena
Lennox
PRC2
Under
girl
mtDNA
pancytopenia
##ecovirimat
isoproterenol
genitourinary
plasticity
premenstrual
hypogonadism
encompass
neurofibromatosis
hydroxybenzyl
megacolon
vulgaris
300
3beta
800
94
AZ
And
BAT
Car
Case
CSC
Conse
Current
CAR
DR
DES
Differ
EN
EV
ERC
FB
FL
Fork
LD
LC
Lab
Local
MB
Mech
MAC
MAR
MCA
MRI
MHC
Ni
Nemaline
Pc
PF
Pub
PAL
Qu
RLS
Sn
SASP
UVA
Vs
Val
Women
XI
cir
cust
dasatinib
ech
final
folate
fT3
fused
ge
hab
ii
iM
iPS
kil
lamb
mm
map
nar
nause
nmol
p105
sun
sense
sativa
sonidegib
sternal
ten
tympan
vand
wall
zolpidem
##oa
##oor
##ipro
##c3
##DD
##sA
##sies
##suff
##B2
##yond
##gal
##T2
##TF
##fied
##fold
##28
##ber
##bre
##ds
##PT
##P8
##RA
##EF
##xonic
##AIR
##zen
##Gs
##titu
##entical
##enafil
##onc
##estion
threshold
insp
##alamic
anesthesia
anhydr
##orl
##oration
##anol
##itre
androgen
##arine
##entation
##ing1B
##osed
##osup
##oside
##ulant
##ulism
##acarb
##olab
##etanib
##idium
##opsy
##oconstr
##ode
genital
stall
stained
start
##ellar
##ellosis
##thral
dead
deposition
Therapy
acroc
extr
exonic
begin
##phase
chor
chord
##NAcal
orphan
comb
##vels
onto
whorl
recalcit
implant
incid
##porin
enacarb
##omegal
associate
haemat
apolipoprotein
phag
##athrin
##ylic
##ostatic
spind
preoperative
pretreatment
##arities
evol
evening
##ologists
intersti
##uba
surround
suggestive
##ophen
uni
unicoronal
cysteine
biallelic
sucrose
dementia
blot
##plex
autonomic
autopsy
##acetic
##illed
nucleolar
Alt
Alpers
endpoint
octa
outer
outside
decisions
##posite
database
scales
trich
106
perin
peric
##ember
microg
microM
complementation
acidic
modeling
deficiencies
mei
##pha1
TRbeta
Chronic
Chk2
##ascul
##neur
##oinsuff
postp
immuno
immunoglobulin
cytochrom
CD8
dysph
##ACE
intravesical
changed
combining
ultimately
investigations
##ptomatic
Another
monthly
fibers
thyroiditis
insulator
insomnia
silicon
organized
hyd
lymphocytic
Statin
chemokine
##APK2
performing
influx
influenced
##eliac
became
migalastat
initiating
##oclasts
lowering
##vised
##AM1
explo
##eletion
pharmacology
stimulating
minim
mineral
technical
Amyotrophic
Amiodarone
##ocardial
mammary
caps
osteoc
osteoclasts
##ileptic
except
Exon
mortem
PINT
##125
hydrocephal
precise
vasoconstr
strands
viruses
Canagliflozin
greatly
embryos
##heumatic
cyclin
Arthritis
##NCE
##aparesis
screened
achondroplasia
duplic
disrupt
##specific
looping
catabol
iodide
tubocur
granul
generates
segment
amyloidosis
Severity
relationships
uncertain
uncontrolled
predispose
thrombophilia
exonucle
depending
mucosa
axitinib
reversal
transmission
amyloidoses
mesylate
intercalation
quantification
goitre
neurodegeneration
phosphaturic
TIAM1
morphological
peak
carbonic
cytosolic
EDN3
participates
focusing
amplified
labeled
TSC2
CHD
##mitted
##rospinal
overload
positioning
codon
codes
medicine
valuable
##otropy
correct
ICAM
stabilization
stabilizes
Develop
analogs
hemangiomas
fluorescence
MAPKAPK2
calst
catalyz
sulfonyl
DITPA
midazolam
Selen
hams
hypermethylated
cerebrospinal
linearity
baloxavir
centrom
tendon
dissip
examples
African
IHPS
RIP1
RIP3
requiring
plasmepsin
haemorrhage
##ocysteine
adjunctive
##omatous
existence
adjusting
Plasmeps
PPTP
proximity
exert
transferred
reached
##thyroid
evident
pentraxin
hairy
elucidate
yielded
NRAS
RNAPII
immunohistochemistry
DDX
Pacritinib
South
Southeast
augmentation
abortion
Similar
Similarly
Malignant
TAZ
hESC
##articles
reserved
physicians
publicly
Deficiency
GalNAcal
Psoriasis
Systemic
easy
pleiotropic
unexpl
autophagic
Chromatin
Disorder
North
dendritic
diminished
Thalidomide
depolarizations
sensitize
Formula
TDP
harmful
hundreds
mAbs
uncommon
Increased
GlyRS
haploinsuff
mapped
##prising
##microscopic
##ummell
spreading
ITIH3
LINC
karyotype
archaea
nonsyn
Disruption
frontotemporal
xenografts
OMIM
Potential
##itudinal
stromal
clarify
glucuronide
Assessment
peroxisomal
Bayes
Following
K27M
paediatric
ventilation
Thyroid
destruction
##luorescence
GFI1B
mosaicism
6q24
DUSP8
Fifty
Korean
XPF
destabil
recessively
Ednrb
dihydroxyphenyl
AZD
ERCC1
MARs
Vsr
custom
narrow
nausea
vandetanib
anhydrase
acrocentric
recalcitrant
enacarbil
spindle
interstitial
octave
cytochrome
hydrocephalus
tubocurarine
sulfonylurea
GalNAcalpha1
haploinsufficiency
82
Aug
AED
BS
BID
Beh
BART
Cor
Coc
Cerebral
DX
Dep
Due
EX
Even
Erb
Eco1
FI
Fer
Four
GER
Glu
Golimumab
Hb
HA
HDL
HSCs
JN
KL
Kummell
LR
LS
Mes
Mat
Mel
NO
NCT
NHL
Op
Ol
Org
Pi
PE
PG
Pers
Peri
Pred
QOL
RC
Rep
Radi
REC
RING
Sa
SY
Sno
Tre
Up
WHO
YAP
Zinc
af
aplastic
bip
coch
center
duc
domes
draw
foss
flex
favour
gated
gren
gfi
laryn
lenalidomide
md
marg
nutri
ov
pac
pestic
run
sal
sizes
suture
sno
tax
ward
##tent
##haps
##rus
##pir
##iBi
##lox
##lamp
##D2
##sen
##sia
##eech
##nis
##ning
##ners
##navir
##BV
##yle
##go
##Ts
##1C
##fort
##620
##6A2
##519
##vical
##vlim
##85
##9C
##9me
##HS
##SH
##SE
##SS
##SIS
##xed
##3a
##31
##300
##MP
##MM
##LED
##G1
##WI
##ono
##onidine
##inergic
thick
##educt
##edolizumab
input
inositol
##alanine
##atase
##atures
##atumumab
anion
##oride
##ican
##itumumab
##arp
##rete
##eclamp
##ositive
##actions
##olus
##olism
##etaxel
##usive
##lym
##urable
##idation
##umulating
##utor
##igm
##ocor
##ilimumab
##odend
##mentary
stay
cond
conserv
##ellent
##tinely
beyond
##stances
##irst
##irilaz
##adow
##adnavir
resemb
resource
##pling
##eptions
recursive
imm
##astr
transgenesis
transthyretin
regurg
enrolled
##sevi
adher
##ectant
associating
clathrin
attrac
##trypt
compelling
compromised
wean
wear
##athion
signatures
Integr
speech
preeclamp
infil
metformin
##indler
agre
##oreg
##ending
##istance
develops
abuse
coinc
pathologies
hypot
##ensus
nonsel
paraparesis
studying
presynaptic
chromom
uns
unit
unable
unequ
unilateral
idea
identical
polar
medium
##ammatory
biased
biodeg
demethylase
consists
consensus
phosphoprotein
bruc
decapping
formalin
overt
detri
survivin
##amines
undifferentiated
undulant
true
pert
perhaps
prednis
##radable
serving
##outh
accoun
synerg
synaps
synaptic
systolic
hyperprolactin
##phae
Chem
Chang
Character
Channel
sections
undert
throughput
inducers
203
processed
eligible
##ACs
failing
combinations
126
120
124
Ang
Anemia
esophageal
skipping
oxal
##ulinum
contributor
sarcomere
discrete
refrig
correlations
##NDING
hyphae
RASA
Stress
plasmin
synthesized
metabolites
fruit
determinant
##ISA
##22A
heterochrom
becoming
Pharmaceutical
hepadnavir
##RP3
migr
glycine
##EST
##tually
experiment
measuring
##tibular
establishes
pharmacogenomics
quar
localize
dosed
IL6
adjust
##ULSIS
distress
exception
PIN
##CHiBi
property
partners
Clonidine
sets
hydrochloride
##opoiesis
crest
##otoxicity
##standing
pseudo
tempor
template
cycles
lengths
##espan
evolutionarily
diffus
##lings
Only
Poly
MoRFCHiBi
SDHD
SDHC
SDHB
personal
incontinentia
encephalomy
00001
hypothes
heterogeneity
ribos
GBS
macroH2A
mesothelioma
massive
intercalator
025
feeding
tachyarrhythm
epidem
##activation
carried
copies
morphogenesis
plantar
focuses
JNK1
PKC
Complex
arrested
ERK1
SSRI
substitu
CD59
stimuli
34a
cervical
##mittent
highlighting
hydroxytrypt
aberrantly
BMI
visc
summary
OPG
ICU
consuming
validation
oculo
ubiquitously
DIND
GAGA
vestibular
internal
summarize
digital
cerebro
SLC6A2
SLC22A
Consid
separated
Cells
dissoci
challenging
enabled
